Study to Evaluate the Safety and Antiviral Activity of Inarigivir Soproxil (Formerly: GS-9992) Plus Tenofovir Alafenamide (TAF) for 12 Weeks in Adults With Chronic Hepatitis B (CHB)
Clinical trial NCT03434353 · TERMINATED
Trial details
- NCT number
- NCT03434353
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-28
- Primary completion
- 2020-01-20
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.